SHP2 Inhibitor Protects AChRs From Effects of Myasthenia Gravis MuSK Antibody

Neurology: Neuroimmunology and NeuroInflammation - United States
doi 10.1212/nxi.0000000000000645
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Myasthenia Gravis With Anti-MuSK Antibody, Showing Progressive Muscular Atrophy Without Blepharoptosis

Internal Medicine
Internal MedicineMedicine
2005English

Peripheral Plasmablasts in Anti-MuSK Myasthenia Gravis

Neuroimmunology and Neuroinflammation
NeurologyImmunology
2017English

Infantile Onset Myasthenia Gravis With MuSK Antibodies

Pediatric Neurology Briefs
2006English

Drug Effects on Myasthenia Gravis

Journal of Clinical Case Reports
2014English

Disease Specific Enrichment of Circulating Let-7 Family microRNA in MuSK+ Myasthenia Gravis

Journal of Neuroimmunology
AllergyImmunologyNeurology
2016English

Rituximab Is Successful in an HIV-positive Patient With MuSK Myasthenia Gravis

Neurology
Neurology
2011English

Myasthenia Gravis

CMAJ
Medicine
2018English

Myasthenia Gravis

Postgraduate Medical Journal
Medicine
1965English

Myasthenia Gravis

Seminars in Neurology
Neurology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy